0 Cart
Added to Cart
    You have items in your cart
    You have 1 item in your cart
    Total
    Check Out Continue Shopping
    `

    beta Amyloid 1-42 Polyclonal Antibody, HRP Conjugated

    Overview
    Catalog # bs-0107R-HRP
    Product Name beta Amyloid 1-42 Polyclonal Antibody, HRP Conjugated
    Applications WB, IHC-P
    Reactivity Human, Mouse, Rat
    Specifications
    Conjugation HRP
    Host Rabbit
    Source KLH conjugated synthetic peptide of human beta-Amyloid(1-42)
    Immunogen Range 672-713/770
    Clonality Polyclonal
    Isotype IgG
    Concentration 1ug/ul
    Purification Purified by Protein A.
    Storage Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% Gentamicin. Store at 4°C for 12 months.
    Target
    Gene ID 351
    Swiss Prot P05067
    Subcellular location Extracellular, Secreted
    Synonyms AAA; AD1; PN2; ABPP; APPI; CVAP; ABETA; PN-II; CTFgamma; Amyloid beta A4 protein; APP; Alzheimer disease amyloid protein; Cerebral vascular amyloid peptide; PreA4; Protease nexin-II; A4
    Background The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.